Current results on the use of imatinib mesylate in patients with relapsed Philadelphia chromosome positive leukemia after allogeneic or syngeneic hematopoietic stem cell transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples